entertainment -WSS

entertainment

author：leisure time 2025-09-28 18:47:33 - browse：6

Several amyloid plaques forming between neurons in a brain — Amyloid plaques forming between neurons. Adobe

The Food and Drug Administration on Thursday granted full approval to the first therapy for Alzheimer’s disease clearly shown to slow the cognitive decline associated with the disease — a milestone in treatment, even if the benefits are modest.

The drug, called Leqembi, was developed by Eisai, the Japanese pharmaceutical company, and sold in partnership with Biogen. It previously secured conditional approval in January. The FDA’s decision will broaden patient access to the drug under the Medicare program and is likely to boost sales, even as Leqembi’s benefits and safety risks continue to be a source of debate.

Leqembi’s full, or traditional, approval was supported by results of a large clinical trial in which the drug slowed the rate of cognitive and functional decline by 27% compared to a placebo. Leqembi also beat placebo on a series of secondary measures of Alzheimer’s, and it had a dramatic effect on clearing toxic brain plaques called beta-amyloid, which play a role in the progression of the disease.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： iTeos Therapeutics debuts first data on TIGIT

Wikipedia

WSS

Lab trade group sues FDA to halt regulation of lab

Ph.D. graduate surprised with gift registry: 'You deserve to be celebrated'

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

Supreme Court shows surprising restraint in chaotic year of crises: ANALYSIS

What will save rural psychiatry services? Higher Medicaid payments

Supreme Court shows surprising restraint in chaotic year of crises: ANALYSIS

explore

entertainment

hotspot

What does generative AI mean for health care? We asked experts

Dramatic video released of Russian fighter jets 'harassing' US drones over Syria

Cancer drug shortages should be causing more outrage

City of Memphis, police chief oppose effort to delay lawsuit in Tyre Nichols case

Supreme Court strikes down use of affirmative action

A bus careens into a gulch in southern Mexico, leaving 27 people dead

Guidelines to prevent youth baseball injuries need more muscle

Stigma and the return of syphilis

Medicare details structure of new drug price negotiation program

Stigma and the return of syphilis

focus

Startling documents reveal new facets of Sacklers' opioid empire

Accuser says Kevin Spacey grope wasn't a caress: ‘It was like a cobra ... angry’

Suspect in Ukraine detonates explosives at a courthouse, killing himself and wounding 2 officers

Myanmar's Supreme Court hears arguments in 2 appeals by ousted leader Aung San Suu Kyi

Man pleads guilty to raping Ohio girl who ended up traveling across state lines for abortion

Biden's Plan B on student loan forgiveness relies on Higher Education Act: What to know

Wikipedia

explore

Wikipedia

explore